Similar articles

• EPO--one year later. Fighting anemia in the courtroom.

  Riley JB Jr, Pristave RJ. Riley JB Jr, et al. Nephrol News Issues. 1990 May;4(5):27. Nephrol News Issues. 1990. PMID: 2348877 No abstract available.
• EPO--one year later. The challenges for the social worker.

  Antonoff A. Antonoff A. Nephrol News Issues. 1990 May;4(5):24, 29. Nephrol News Issues. 1990. PMID: 2348875 No abstract available.
• Excessive level of parathyroid hormone may induce the reduction of recombinant human erythropoietin effect on renal anemia.

  Fujita Y, Inoue S, Horiguchi S, Kuki A. Fujita Y, et al. Miner Electrolyte Metab. 1995;21(1-3):50-4. Miner Electrolyte Metab. 1995. PMID: 7565462
• [Erythropoietin: its biological properties and clinical use].

  Ermolenko VM, Nikolaev AIu. Ermolenko VM, et al. Ter Arkh. 1990;62(11):141-5. Ter Arkh. 1990. PMID: 2094979 Review. Russian. No abstract available.
• [Treatment of renal anemia using synthetic human erythropoietin].

  Blumberg A, Zehnder C. Blumberg A, et al. Ther Umsch. 1988 Dec;45(12):895-9. Ther Umsch. 1988. PMID: 3065970 Review. German. No abstract available.